IL162381A0 - A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine - Google Patents

A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine

Info

Publication number
IL162381A0
IL162381A0 IL16238102A IL16238102A IL162381A0 IL 162381 A0 IL162381 A0 IL 162381A0 IL 16238102 A IL16238102 A IL 16238102A IL 16238102 A IL16238102 A IL 16238102A IL 162381 A0 IL162381 A0 IL 162381A0
Authority
IL
Israel
Prior art keywords
preparation
recombinant dna
dna construct
anthrax vaccine
toxic
Prior art date
Application number
IL16238102A
Other languages
English (en)
Original Assignee
Rakesh Bhatnagar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakesh Bhatnagar filed Critical Rakesh Bhatnagar
Publication of IL162381A0 publication Critical patent/IL162381A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16238102A 2001-12-05 2002-03-20 A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine IL162381A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1222DE2001 2001-12-05
PCT/IN2002/000048 WO2003048390A1 (fr) 2001-12-05 2002-03-20 Procede de preparation d'un vaccin non toxique contre l'anthrax

Publications (1)

Publication Number Publication Date
IL162381A0 true IL162381A0 (en) 2005-11-20

Family

ID=11097141

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16238102A IL162381A0 (en) 2001-12-05 2002-03-20 A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine

Country Status (12)

Country Link
US (1) US7888490B2 (fr)
EP (2) EP1453534A1 (fr)
JP (1) JP2005511059A (fr)
CN (1) CN1694722A (fr)
AU (1) AU2002242935A1 (fr)
BR (1) BRPI0215039A2 (fr)
CA (1) CA2469671A1 (fr)
IL (1) IL162381A0 (fr)
MX (1) MXPA04005538A (fr)
RU (1) RU2287581C2 (fr)
WO (1) WO2003048390A1 (fr)
ZA (1) ZA200404444B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481043B2 (en) * 2001-06-22 2013-07-09 Cpex Pharmaceuticals, Inc. Nasal immunization
WO2005081749A2 (fr) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Anticorps humains neutralisants diriges contre la toxine du charbon
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
US8409590B2 (en) 2004-02-11 2013-04-02 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
EP1954307A4 (fr) * 2005-11-14 2009-12-02 Univ Maryland Biotech Inst Vaccins oraux a base de salmonelle contre l'anthrax
CN100362094C (zh) * 2006-02-14 2008-01-16 中国人民解放军军事医学科学院生物工程研究所 一株无pX01和pX02质粒的炭疽杆菌菌株及其用途
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
US7794732B2 (en) * 2006-05-12 2010-09-14 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
WO2008152654A1 (fr) * 2007-06-11 2008-12-18 Panacea Biotec Limited Protéines hybrides du charbon, compositions et leurs applications
WO2008152655A1 (fr) * 2007-06-11 2008-12-18 Panacea Biotec Limited Limited Protéines hybrides du charbon, compositions et leurs applications
RU2355769C1 (ru) * 2007-11-23 2009-05-20 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук СПОСОБ ПОЛУЧЕНИЯ ФУНКЦИОНАЛЬНО АКТИВНОГО РЕКОМБИНАНТНОГО БЕЛКА ЛЕТАЛЬНОГО ФАКТОРА СИБИРСКОЙ ЯЗВЫ (LF), РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pETGST-LFmin, КОДИРУЮЩАЯ АКТИВНЫЙ БЕЛОК LF, И ШТАММ Escherichia coli BL-GSTLFmin, ПРОДУЦИРУЮЩИЙ АКТИВНЫЙ БЕЛОК ЛЕТАЛЬНОГО ФАКТОРА СИБИРСКОЙ ЯЗВЫ
RU2361921C1 (ru) * 2007-11-23 2009-07-20 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН СПОСОБ ПОЛУЧЕНИЯ ФУНКЦИОНАЛЬНО АКТИВНОГО РЕКОМБИНАНТНОГО БЕЛКА ЛЕТАЛЬНОГО ФАКТОРА ЯЗВЫ (LF), РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pETHIS-LF, КОДИРУЮЩАЯ АКТИВНЫЙ БЕЛОК LF И ШТАММ ESCHERICHIA COLI BL-HISLF, ПРОДУЦИРУЮЩИЙ АКТИВНЫЙ БЕЛОК ЛЕТАЛЬНОГО ФАКТОРА СИБИРСКОЙ ЯЗВЫ
AU2009299615B2 (en) 2008-10-02 2015-07-16 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
RU2410699C1 (ru) * 2009-11-13 2011-01-27 Федеральное государственное учреждение здравоохранения Волгоградский научно-исследовательский противочумный институт Роспотребнадзора Способ получения диагностикума эритроцитарного сибиреязвенного антигенного для обнаружения антител к протективному антигену
CN101798565B (zh) * 2010-02-26 2013-08-07 中国人民解放军军事医学科学院生物工程研究所 能在芽孢表面展示pa20蛋白的炭疽芽孢杆菌及其应用
WO2012171329A1 (fr) * 2011-06-15 2012-12-20 Du Quan Procédé de séparation d'un acide nucléique et ses applications
CN102516394B (zh) * 2011-12-14 2014-07-09 中国人民解放军军事医学科学院生物工程研究所 CMG2突变体和Fc的融合蛋白及其编码基因与应用
CN105749265B (zh) * 2016-03-30 2020-03-27 中国疾病预防控制中心传染病预防控制所 一种二价炭疽疫苗
CN105797148B (zh) * 2016-03-30 2020-01-14 中国疾病预防控制中心传染病预防控制所 一种无毒炭疽活疫苗及无毒炭疽菌株
NL2030835B1 (en) 2020-01-24 2022-12-29 Aim Immunotech Inc Methods, compositions, and vaccinces for treating a virus infection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2017606A (en) 1932-12-24 1935-10-15 Sharp & Dohme Inc Anthrax antigen preparation and product
US2151364A (en) 1937-06-02 1939-03-21 Cutter Lab Anthrax vaccine
RU2115433C1 (ru) 1992-08-28 1998-07-20 Научно-исследовательский институт микробиологии МО РФ Вакцина сибиреязвенная комбинированная
GB9618107D0 (en) * 1996-08-30 1996-10-09 Secr Defence Vaccine production
CA2337966A1 (fr) * 1998-07-10 2000-01-20 U.S. Medical Research Institute Of Infectious Diseases Vaccin contre l'intoxication par les staphylocoques
FR2798291B1 (fr) * 1999-09-10 2005-01-14 Pasteur Institut Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
EP1244687A4 (fr) * 1999-12-22 2005-06-15 Univ Ohio State Res Found PROCEDES DE PROTECTION CONTRE L'INFECTION LETALE PAR LE i BACILLUS ANTHRACIS /i
EP1278764A4 (fr) * 2000-05-04 2004-05-19 Harvard College Traitement et prevention d'infections bacteriennes et composes a cet effet
WO2002100340A2 (fr) * 2001-06-08 2002-12-19 Avant Immunotherapeutics, Inc. Vaccin ameliore contre l'anthrax
GB0116798D0 (en) * 2001-07-10 2001-08-29 Secr Defence Expression system
GB0126266D0 (en) * 2001-11-01 2002-01-02 Microbiological Res Authority Anthrax antigenic compositions

Also Published As

Publication number Publication date
RU2287581C2 (ru) 2006-11-20
US20050063986A1 (en) 2005-03-24
AU2002242935A8 (en) 2003-06-17
EP1958960A2 (fr) 2008-08-20
EP1958960A3 (fr) 2009-01-07
MXPA04005538A (es) 2005-06-08
RU2004120293A (ru) 2005-04-20
BRPI0215039A2 (pt) 2016-06-28
ZA200404444B (en) 2006-03-29
WO2003048390A1 (fr) 2003-06-12
US7888490B2 (en) 2011-02-15
AU2002242935A1 (en) 2003-06-17
CN1694722A (zh) 2005-11-09
JP2005511059A (ja) 2005-04-28
CA2469671A1 (fr) 2003-06-12
EP1453534A1 (fr) 2004-09-08
WO2003048390A8 (fr) 2004-02-05

Similar Documents

Publication Publication Date Title
IL162381A0 (en) A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine
HUP0402471A3 (en) Vaccine
HUP0402259A3 (en) Vaccines
GB0407935D0 (en) Vaccine
GB0306611D0 (en) Novel vaccine
IL157498A0 (en) Vaccine
GB2393122B (en) Improved vaccination against anthrax
GB0121171D0 (en) Vaccine
ZA200306573B (en) A vaccine composition and method of using the same
PT1372712E (pt) Vacina de vírus herpes equino
AU2002367108A1 (en) Dna vaccine for periodontal disease
IL145440A0 (en) Synthetic hcv envelope proteins and their use for vaccination
GB0105606D0 (en) Immunogens and vaccines and their preparation and use
GB0105238D0 (en) Vaccines
AU2002347346A8 (en) Dna vaccine
AU2002322013A1 (en) Therapeutic dna vaccination
AU2002258268A1 (en) Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
GB0119271D0 (en) DNA Vaccine
GB0100785D0 (en) Nucleic acid vaccine
HUP0104622A3 (en) Human influenza vaccine composition with increased activity and process for the preparation thereof
GB0129338D0 (en) Vaccination
GB0130823D0 (en) Vaccine
GB0124137D0 (en) Vaccine
GB0103867D0 (en) Vaccine
GB0128312D0 (en) Vaccine